LC
NVO

Landaas & Company’s Novo Nordisk NVO Stock Holding History

Landaas & Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,354
Closed -$77K – 229
2018
Q2 		$77K Buy
+3,354
New +$79.7K 0.06% 110
2018
Q1 		– Sell
-3,342
Closed -$90K – 223
2017
Q4 		$90K Hold
3,342
– – 0.08% 103
2017
Q3 		$80K Buy
+3,342
New +$75.5K 0.07% 110

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Landaas & Company's NVO Position: Q3 2018 in Review

Landaas & Company sold out of Novo Nordisk (NVO) in Q3 2018, closing a stake of 3,354 shares — an estimated $77K sold.

Landaas & Company first reported a position in NVO in Q3 2017 and held it in 3 quarters. The position peaked at $90K in Q4 2017. 558 funds tracked by Wall St. Rank hold NVO as of Q3 2018.

  • Landaas & Company reported no remaining Novo Nordisk position as of Q3 2018 after selling out during the quarter.
  • Landaas & Company sold 3,354 Novo Nordisk shares in Q3 2018, an estimated $77K.
  • Landaas & Company first reported a position in Novo Nordisk in Q3 2017 and held it in 3 quarters.
  • Landaas & Company's Novo Nordisk position peaked at $90K in Q4 2017.
  • 558 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.